New Likely modest benefit Published May 11, 2026
Berberine for Total Cholesterol: What 23 Trials Show
Direct answer
Berberine appears to lower total cholesterol. Across 23 trials with 11704 participants, the average drop was -14.08 mg/dL; the studies support that average effect, but the numbers available here do not pin down a precise range around it.1417 That is about 70% of the smallest change usually treated as clinically noticeable, so think real nudge, not dramatic overhaul. The evidence is consistent and strong overall, even though the average size of the drop stays moderate.1314
23 studies · 11,704 participants · typical duration 13 wk · 20 sources
Berberine shows up in cholesterol conversations because total cholesterol is the bluntest number on a routine lipid panel—and the easiest one to fixate on after a lab test. The real question is not whether berberine moves that number at all, but whether it moves it enough to matter.14
Across 23 trials, berberine moves total cholesterol in the right direction, but the average shift stays moderate rather than dramatic.1417 That matters if you're deciding whether a 13-week trial and a repeat blood test are worth the effort.1417
How it works
Berberine seems to make the liver act less like a warehouse storing cholesterol and more like a pickup hub clearing it from the blood. It boosts cell-energy signaling and increases the receptors that grab cholesterol-rich particles, so more of that traffic gets pulled out of circulation instead of lingering on the road.913 It also appears to affect bile-acid and lipid-handling pathways, which helps explain why the cholesterol signal shows up across several metabolic conditions instead of one narrow group.714
What the studies show
The big-picture result is simple: across 23 randomized trials and 11704 participants, berberine lowered total cholesterol by -14.08 mg/dL on average.1417 That is a measurable improvement, but it does not reach the 20.0 mg/dL threshold usually treated as the smallest clinically noticeable shift on this marker.14
That scale matters for expectations. A -14.08 mg/dL change works out to about 70% of the smallest noticeable shift, so berberine lands in the real-but-modest zone rather than the dramatic-change zone.14 If your total cholesterol sits only a little above target, that nudge can matter. If you need a large drop, the average trial result does not suggest berberine does that on its own.1314
The signal also does not depend on one isolated study. Reviews published across different years keep pointing in the same direction, and randomized trials in people with fatty liver, diabetes, obesity, and dyslipidemia report lipid improvements that fit the pooled result.2381220
A mechanistic trial adds a useful reality check: berberine did not just move numbers randomly; it shifted pathways tied to how the body handles lipids and energy.9 That kind of biological fit makes the cholesterol result more believable.
The main limitation is not whether berberine works at all, but how far you can expect it to go. Studies used different formulations and mixed populations, and the typical study lasted 13 weeks, so the evidence tells you much more about a few months of use than about taking berberine indefinitely.671417
Caveats worth knowing
- ·
- ·
- ·
- ·
The average drop, -14.08 mg/dL, stays below the 20.0 mg/dL threshold usually treated as a clinically noticeable shift.14
Watch-outs
-
GI side effects are the main tradeoff
Digestive complaints show up most often in the berberine literature, including constipation, diarrhea, and nausea. In lipid-focused trials, these were usually mild rather than serious.28
Severity: low
-
Headache shows up in some studies
Headache appeared in some berberine research, including a pharmacokinetic study of a berberine formulation. It is not the dominant problem, but it is a recurring minor complaint.7
Severity: low
Practical guidance
A research-matched way to try berberine is to copy an actual trial rather than guess. One randomized NAFLD study used 500 mg three times daily with meals.3 Most cholesterol studies ran about 13 weeks, so rechecking your lipid panel after roughly 3 months matches the evidence much better than judging it after a few days.1417
Stop earlier if constipation, diarrhea, nausea, or headache stop feeling like a short adjustment and start feeling like a pattern.27 And keep expectations grounded: the average effect is -14.08 mg/dL, so berberine makes more sense as a measured experiment with follow-up labs than as a dramatic one-shot fix.14
People also ask
Does berberine actually lower cholesterol?
What is the best supplement to lower high cholesterol?
What's the downside of taking berberine?
How long does it take for berberine to lower LDL?
Is there a downside to taking berberine?
What organ is berberine hard on?
Sources
Sources
- 1. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. ↑
- 2. The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials. ↑
- 3. Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease. ↑
- 4. The Therapeutic Effect of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis. ↑
- 5. Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease. ↑
- 6. Berberine and Dyslipidemia: Different Applications and Biopharmaceutical Formulations Without Statin-Like Molecules-A Meta-Analysis. ↑
- 7. Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia. ↑
- 8. Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. ↑
- 9. Effect of Berberine on Cardiovascular Disease Risk Factors: A Mechanistic Randomized Controlled Trial. ↑
- 10. Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study. ↑
- 11. The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ↑
- 12. The Effect of Berberine on Lipid Profile, Liver Enzymes, and Fasting Blood Glucose in Patients with Non-alcoholic Fatty Liver Disease (NAFLD): A Randomized Controlled Trial. ↑
- 13. The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis. ↑
- 14. Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. ↑
- 15. The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review. ↑
- 16. A 30-Day Randomized Crossover Human Study on the Safety and Tolerability of a New Micellar Berberine Formulation with Improved Bioavailability. ↑
- 17. Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials. ↑
- 18. Biochemical changes associated with non-alcoholic fatty liver disease in response to berberine treatment: a systematic review and meta-analysis of clinical and preclinical research. ↑
- 19. A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes. ↑
- 20. Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial. ↑